Acm. Kobold et al., LEVELS OF SOLUBLE FC-GAMMA-RIII CORRELATE WITH DISEASE SEVERITY IN SEPSIS, Clinical and experimental immunology, 114(2), 1998, pp. 220-227
Neutrophil activation is thought to play a crucial role in the pathoge
nesis of sepsis. During activation, neutrophils adhere to and migrate
through the endothelium. Therefore, the amount of circulating neutroph
ils does not adequately reflect the total amount of neutrophils that a
re involved in the pathophysiologic process of this condition. In this
study we test the hypothesis that the severity of sepsis is associate
d with the total body mass of neutrophils as reflected in the plasma c
oncentration of soluble Fc gamma receptor type III (sFc gamma RIII). N
ineteen patients with sepsis (12 male, seven female, median age of 69
years, range 29-87 years) were included in this study. Ten healthy vol
unteers served as controls. Plasma sFc gamma RIII concentrations were
measured by ELISA. Other parameters that were studied were leucocyte c
ount, plasma concentrations of lactoferrin and soluble L-selectin, and
surface expression of CD11b and CD66b on circulating neutrophils. Dis
ease activity was measured using the Acute Physiology and Chronic Heal
th Evaluation (APACHE) II score. Soluble Fc gamma RIII levels were ele
vated in sepsis patients whereas soluble L-selectin levels were modera
tely decreased compared with healthy controls. Markers of cell activat
ion were significantly increased in sepsis patients. Soluble Fc gamma
RIII correlated with disease severity as measured by the APACHE score
(P < 0.05, r = 0.53), whereas the other parameters did not correlate w
ith the APACHE score. In conclusion, this study demonstrates that solu
ble Fc gamma RIII is a useful marker for disease severity in patients
with sepsis.